Treatment of otitis media by sublingual administration of DNA

Details Treatment of otitis media by sublingual administration of DNA Treatment of otitis media by sublingual administration of DNA

1998-07-28

1999-09-07

Crouch, Deborah

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

536 221, 514 2, 514 47, 514 50, 424 92, A01N 4304, A61K 3170

Patent

active

059487682

ABSTRACT:
Methods for treating symptoms of otitis media in a patient, are presented. Methods comprise administering an effective amount of DNA to a subject in a manner so as not to effect gene transfer.

REFERENCES:
patent: 5240846 (1993-08-01), Collins et al.
patent: 5292498 (1994-03-01), Boucher, Jr.
patent: 5420116 (1995-05-01), Puchelle et al.
patent: 5470838 (1995-11-01), von Borstel et al.
patent: 5726160 (1998-03-01), McMichael
Canonico, A.E. et al., "Expression of a CMV Promoter Driven Human .alpha.-1 Antitrypsin Gene in Cultured Lung Endothelial Cells and in the Lungs of Rabbits," Clin. Res., 39(2): 219A (1991).
Ledley, F.D., "Non-viral gene therapy," Current Opinion in Biotechnology, 5: 626-636 (1994).
Ledley, F.D., "Nonviral Gene Therapy: The Promise of Genes as Pharmaceutical Products," Human Gene Therapy, 6: 1129-1144 (Sep., 1995).
Rosenfeld, M.A. et al., "Adenovirus-Mediated Transfer of a Recombinant .alpha.1-Antitrypsin Gene to the Lung Epithelium in Vivo," Science, 252: 431-434 (Apr. 19, 1991).
Marshall, E., "Gene Therapy's Growing Pains," Science, 269: 1050-1055 (Aug. 25, 1995).
Alton, E.W.F.W. et al., "Noninvasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice," Chemical Abstracts, 119(21):62 (Nov. 22, 1993) (Absract 217089w).
Flotte, T.R., et al., "Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector," Chemical Abstracts, 120(5):229 (Jan. 31, 1994) (Abstract 46918e).
Textbook of Respiratory Medicine, John F. Murray, ed., W.B. Saunders Company, Harcourt Brace Jovanovich, Inc., Philadelphia, PA, p. 1038 (1988).
Klein, J.O. Clinical Infectious Diseases, vol. 19, pp. 823-833, 1994.
Berman, S. Pediatrics, vol. 96, No. 1, pp. 126-131, Jul. 1995.
Karver Ear, Nose and Throat disorders, vol. 25, No. 3, pp. 619-632, Sep. 1998.
Baker, Pediatric Annals, vol. 20, No. 11, pp. 591-593, 596-598, Nov. 1991.
Rosenfeld et al. Primary care, clinics in office practice, vol. 23, pp. 677-685, 1996.
Dagan et al. Ear, Nose and Throat Journal, vol. 77, pp. 16-19, Jun. 1998.

Affiliated with

Also associated with

Rating

Treatment of otitis media by sublingual administration of DNA does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of otitis media by sublingual administration of DNA, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of otitis media by sublingual administration of DNA will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1804628